sb 203580 has been researched along with Halitosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ii, H; Imai, T; Kamoda, T; Murata, T; Sato, T; Yaegaki, K | 1 |
| Ekuni, D; Ii, H; Imai, T; Irie, K; Morita, M; Yaegaki, K | 1 |
2 other study(ies) available for sb 203580 and Halitosis
| Article | Year |
|---|---|
Oral malodorous compound inhibits osteoblast proliferation.
Topics: 3T3 Cells; Alkaline Phosphatase; Animals; Butadienes; Cell Differentiation; Cell Proliferation; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Halitosis; Humans; Hydrogen Sulfide; Imidazoles; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nitriles; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines | 2009 |
Oral malodorous compound induces osteoclast differentiation without receptor activator of nuclear factor κB ligand.
Topics: Acid Phosphatase; Animals; Blotting, Western; Calcium Phosphates; Calcium-Calmodulin-Dependent Protein Kinases; Cathepsin K; Cell Differentiation; Cell Line; Enzyme Inhibitors; Flavonoids; Halitosis; Hydrogen Sulfide; Imidazoles; Isoenzymes; Macrophages; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoclasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; RANK Ligand; Tartrate-Resistant Acid Phosphatase | 2010 |